These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 823844)

  • 21. Substance P induces granulocyte infiltration through degranulation of mast cells.
    Matsuda H; Kawakita K; Kiso Y; Nakano T; Kitamura Y
    J Immunol; 1989 Feb; 142(3):927-31. PubMed ID: 2464033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of the survival of in-vitro cultivated rat peritoneal mast cells in presence of disodium cromoglycate].
    Baeckeland E
    C R Seances Soc Biol Fil; 1972; 166(4):727-30. PubMed ID: 4631302
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of chopped rat lung on the inhibitory actions of prostaglandins, isoprenaline, theophylline and disodium cromoglycate on mast cell degranulation.
    Taylor WA; Sheldon D
    Monogr Allergy; 1977; 12():159-63. PubMed ID: 411025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disodium cromoglycate, a mast-cell stabilizer, alters postradiation regional cerebral blood flow in primates.
    Cockerham LG; Doyle TF; Pautler EL; Hampton JD
    J Toxicol Environ Health; 1986; 18(1):91-101. PubMed ID: 3084803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The significance of chloride in the inhibitory action of disodium cromoglycate on immunologically-stimulated rat peritoneal mast cells.
    Law JK; Yeung CK; Wan SP; Ingebrandt S; Lau HY; Rudd JA; Chan M
    Biochim Biophys Acta; 2011 Sep; 1810(9):867-74. PubMed ID: 21635937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of mast cell degranulation by disodium cromoglycate attenuates the development of hypoxic pulmonary hypertension in rats exposed to chronic hypoxia.
    Banasová A; Maxová H; Hampl V; Vízek M; Povýsilová V; Novotná J; Vajnerová O; Hnilicková O; Herget J
    Respiration; 2008; 76(1):102-7. PubMed ID: 18349522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological modulation of IgE-dependent mast cell degranulation in experimental autoimmune uveoretinitis.
    de Kozak Y; Sakai J; Sainte-Laudy J; Faure JP; Benveniste J
    Jpn J Ophthalmol; 1983; 27(4):598-608. PubMed ID: 6422112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental pharmacological studies in the development of disodium cromoglycate].
    Cox JS
    Alergia; 1972 Aug; 20(1):35-46. PubMed ID: 4628933
    [No Abstract]   [Full Text] [Related]  

  • 29. Disodium cromoglycate: a novel gastric antiulcer agent?
    Ogle CW; Lau HK
    Eur J Pharmacol; 1979 May; 55(4):411-5. PubMed ID: 111954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological characterization of a chronic pruritus model induced by multiple application of 2,4,6-trinitrochlorobenzene in NC mice.
    Yamashita H; Makino T; Mizukami H; Nose M
    Eur J Pharmacol; 2007 Jun; 563(1-3):233-9. PubMed ID: 17336291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosine-mediated mast cell degranulation in adenosine deaminase-deficient mice.
    Zhong H; Chunn JL; Volmer JB; Fozard JR; Blackburn MR
    J Pharmacol Exp Ther; 2001 Aug; 298(2):433-40. PubMed ID: 11454903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhibition of mast cell degranulation in monkey gingiva by disodium cromoglycate.
    Nuki K; Farnoush A
    J Periodontal Res; 1975 Nov; 10(5):282-7. PubMed ID: 129550
    [No Abstract]   [Full Text] [Related]  

  • 33. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
    Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
    Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of mast cell degranulation by disodium cromoglycate delayed the regression of hypoxic pulmonary hypertension in rats.
    Maxová H; Vasilková M; Novotná J; Vajnerová O; Bansová A; Vízek M; Herget J
    Respiration; 2010; 80(4):335-9. PubMed ID: 20389049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
    Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B
    Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mast cell degranulation: a comparison of the inhibitory actions of disodium cromoglycate, drugs known to influence the level of intracellular cyclic nucleotide and diisopropylfluorophosphate (DFP).
    Taylor WA; Sheldon D
    Int Arch Allergy Appl Immunol; 1974; 47(5):696-707. PubMed ID: 4372185
    [No Abstract]   [Full Text] [Related]  

  • 37. Suppression of Mast Cell Activation by GPR35: GPR35 Is a Primary Target of Disodium Cromoglycate.
    Oka M; Akaki S; Ohno O; Terasaki M; Hamaoka-Tamura Y; Saito M; Kato S; Inoue A; Aoki J; Matsuno K; Furuta K; Tanaka S
    J Pharmacol Exp Ther; 2024 Mar; 389(1):76-86. PubMed ID: 38290974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current views of the mechanism of action of prophylactic antiallergic drugs.
    González Alvarez R; Arruzazabala ML
    Allergol Immunopathol (Madr); 1981; 9(6):501-8. PubMed ID: 6122370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of mast cell stabilizers in hyperhomocysteinemia-induced cardiac hypertrophy in rats.
    Singh AP; Singh M; Balakumar P
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):596-604. PubMed ID: 18520950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of nedocromil sodium and sodium cromoglycate on human lung mast cells obtained by bronchoalveolar lavage and by dispersion of lung fragments.
    Leung KB; Flint KC; Brostoff J; Hudspith BN; Johnson NM; Pearce FL
    Eur J Respir Dis Suppl; 1986; 147():223-6. PubMed ID: 2429855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.